Synthesis and neuromuscular blocking activity of 16-(2- and 3-pyridylmethylene) dehydroepiandrosterone derivatives

Steroids

Volumn 75, Issue 4-5, 2010, Pages 323-329

  Dubey, Sonal ^a   Sharma, Amit K ^b   Jindal, D P ^c   Harvey, Alan ^d   Singh, Randhir ^b   Bodhankar, S L ^b  

^a KLE UNIVERSITY   (India)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^c PANJAB UNIVERSITY   (India)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Depolarizing competitive antagonism; In vitro and in vivo models; Neuromuscular blockers; Quaternary ammonium compounds

Indexed keywords

16 (2 PYRIDYLMETHYLENE) 3BETA PYRROLIDINO 5 ANDROSTEN 17BETA OL DIMETHIODIDE; 16 (2 PYRIDYLMETHYLENE) 3BETA PYRROLIDINO 5 ANDROSTEN 17BETA YL ACETATE DIMETHIODIDE; 16 (3 PYRIDYLMETHYLENE) 3BETA PYRROLIDINO 5 ANDROSTEN 17BETA OL DIMETHIODIDE; 16 (3 PYRIDYLMETHYLENE) 3BETA PYRROLIDINO 5 ANDROSTEN 17BETA YL ACETATE DIMETHIODIDE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM BROMIDE; PRASTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHICK; COMPETITIVE INHIBITION; CONTROLLED STUDY; DEPOLARIZATION; DRUG DESIGN; DRUG DOSE COMPARISON; DRUG STRUCTURE; DRUG SYNTHESIS; HORMONE SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; NEUROMUSCULAR BLOCKING; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RECTUS ABDOMINIS MUSCLE; SKELETAL MUSCLE; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; ANURA; CHICKENS; DEHYDROEPIANDROSTERONE; MUSCLE, SKELETAL; NEUROMUSCULAR BLOCKING AGENTS; REFERENCE STANDARDS; TIME FACTORS;

EID: 77749338956     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2010.01.009     Document Type: Article

References (14)

1. Copp F.C., and Mogey G.A. Synthetic bis quaternary salts related to d-tubocurarine. Nature 165 (1950) 601-602
2. Hunter J.M. New neuromuscular blocking drugs. N Engl J Med 332 (1995) 1691-1699
3. Speight T.M., and Avery G.S. Pancuronium bromide: a review of its pharmacological properties and clinical application. Drugs 4 (1972) 163-226
4. Bowman W.C., and Webb S.N. Neuromuscular blocking and ganglion blocking activities of some acetylcholine antagonists in the cat. J Pharm Pharmacol 24 (1972) 762-772
5. Barankay A. Circulatory effects of pipecurium bromide during anaesthesia of patients with severe valvular and ischaemic heart diseases. Arzneim-Forsch Drug Res 30 (1980) 386-389
6. Stenlake J.B., Waugh R.B., Urwin J., Dewar G.H., and Coker G.G. Atracurium: conception and inception. Br J Anaesth 55 (1983) 3-13
7. Christiansen RG, Clinton RO, Dean JW, U.S. Patent 316364; 1964, Chem Abstr 1965;62:7834.
8. Vasuki G., Parthasarathi V., Ramamurthi K., Jindal D.P., and Dubey S. 17-Oxo-16-(2-pyridylmethylene)androst-5-en-3β-ol monohydrate. Acta Cryst C 57 (2001) 1-2
9. Easthem J.F., and Taranishi R. In: Adams R. (Ed). Organic synthesis vol. 2 (1960), John Wiley and Sons, Inc., New York 1-28
10. Vasuki G., Thamotharan S., Parthasarathi V., Ramamurthi K., Dubey S., and Jindal D.P. 16-(2-Pyridylmethylene)androst-4-ene-3,17-dione. Acta Cryst E 58 (2002) o753-o755
11. Vasuki G., Parthasarathi V., Ramamurthi K., Dubey S., and Jindal D.P. 16-(3-Pyridylmethylene)androst-4-ene-3,17-dione. Acta Cryst E 58 (2002) o1359-o1360
12. Jindal D.P., Piplani P., Fajarak H., Prior C., and Marshall I.G. Arzneim-Forsch Drug Res 53 (2003) 73-79
13. Dubey S., Jindal D.P., Piplani P., Young L.C., Fathi B., and Harvey A.L. Synthesis and neuromuscular blocking activity of 16β-piperidino epiandrosterone derivatives. Med Chem Res 14 (2005) 229-240
14. Teerapong P., Marshall I.G., Harvey A.L., Singh H., Paul D., Bharwaj T.R., et al. The effects of dihydrochandonium and other chandonium analogues on neuromuscular and autonomic transmission. J Pharm Pharmacol 31 (1979) 521-528